Total planned funding: $340,613,075
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $57,632,657 |
| Zambia | $38,238,475 |
| South Africa | $31,437,168 |
| Zimbabwe | $29,468,423 |
| Tanzania | $28,098,899 |
| Mozambique | $26,810,677 |
| Asia Regional Program | $24,871,345 |
| West Africa Region | $18,148,918 |
| Vietnam | $14,082,181 |
| Rwanda | $11,149,961 |
| Botswana | $8,764,283 |
| Haiti | $7,670,000 |
| Dominican Republic | $5,598,850 |
| Burundi | $5,315,133 |
| Cambodia | $5,250,000 |
| Malawi | $4,966,259 |
| Côte d'Ivoire | $4,645,831 |
| Democratic Republic of the Congo | $4,432,310 |
| Ethiopia | $2,797,803 |
| Eswatini | $2,271,755 |
| Uganda | $2,010,000 |
| India | $1,977,954 |
| Lesotho | $1,638,960 |
| China | $1,500,000 |
| Kenya | $1,256,634 |
| enumerations.Philippines | $300,000 |
| Thailand | $278,599 |
| Indonesia | $0 |
Organizational Types
| NGO | $332,943,075 |
| Implementing Agency | $7,670,000 |
Program Areas
| Prevention | $102,749,609 |
| Treatment | $100,469,872 |
| Care | $68,765,907 |
| Testing | $38,254,962 |
| Governance and Systems | $30,210,431 |
| Management and Operations | $162,294 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $89,118,045 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $60,617,894 |
| HVCT: Testing: HIV Testing and Counseling | $38,254,962 |
| HKID: Care: Orphans and Vulnerable Children | $36,592,811 |
| HBHC: Care: Adult Care and Support | $21,970,186 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $21,267,825 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,876,633 |
| HLAB: Laboratory Infrastructure | $11,078,031 |
| OHSS: Health Systems Strengthening | $9,848,032 |
| HVSI: Strategic Information | $9,284,368 |
| PDTX: Treatment: Pediatric Treatment | $7,928,543 |
| HVTB: Care: TB/HIV | $5,931,051 |
| PDCS: Care: Pediatric Care and Support | $4,271,859 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,468,293 |
| HTXD: Treatment: ARV Drugs | $3,423,284 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,283,964 |
| HMIN: Biomedical Prevention: Injection Safety | $175,000 |
| HVMS: Management and Operations | $162,294 |
| HMBL: Biomedical Prevention: Blood Safety | $60,000 |